Skip to main content
. 2017 Feb;29(1):18–24. doi: 10.21147/j.issn.1000-9604.2017.01.03

1.

1

The PFS analysis of patients with EGFR uncommon mutations treated with EGFR-TKIs. PFS, progression-free survival; EGFR, epidermal growth factor receptor; TKI, tyrosine kinase inhibitor.